Prospects of siRNA applications in regenerative medicine

Fatemeh Mottaghitalab, Ali Rastegari, Mehdi Farokhi, Rassoul Dinarvand, Hossein Hosseinkhani, Keng Liang Ou, Daniel W. Pack, Chuanbin Mao, Meshkat Dinarvand, Yousef Fatahi, Fatemeh Atyabi

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Small interfering RNA (siRNA) has established its reputation in the field of tissue engineering owing to its ability to silence the proteins that inhibit tissue regeneration. siRNA is capable of regulating cellular behavior during tissue regeneration processes. The concept of using siRNA technology in regenerative medicine derived from its ability to inhibit the expression of target genes involved in defective tissues and the possibility to induce the expression of tissue-inductive factors that improve the tissue regeneration process. To date, siRNA has been used as a suppressive biomolecule in different tissues, such as nervous tissue, bone, cartilage, heart, kidney, and liver. Moreover, various delivery systems have been applied in order to deliver siRNA to the target tissues. This review will provide an in-depth discussion on the development of siRNA and their delivery systems and mechanisms of action in different tissues.

Original languageEnglish
Pages (from-to)312-329
Number of pages18
JournalInternational Journal of Pharmaceutics
Volume524
Issue number1-2
DOIs
Publication statusPublished - May 30 2017

Fingerprint

Regenerative Medicine
Small Interfering RNA
Regeneration
Nerve Tissue
Thromboplastin
Tissue Engineering
Cartilage
Technology
Kidney
Gene Expression
Bone and Bones
Liver

Keywords

  • Delivery systems
  • Gene expression
  • siRNA
  • Tissue engineering

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Mottaghitalab, F., Rastegari, A., Farokhi, M., Dinarvand, R., Hosseinkhani, H., Ou, K. L., ... Atyabi, F. (2017). Prospects of siRNA applications in regenerative medicine. International Journal of Pharmaceutics, 524(1-2), 312-329. https://doi.org/10.1016/j.ijpharm.2017.03.092

Prospects of siRNA applications in regenerative medicine. / Mottaghitalab, Fatemeh; Rastegari, Ali; Farokhi, Mehdi; Dinarvand, Rassoul; Hosseinkhani, Hossein; Ou, Keng Liang; Pack, Daniel W.; Mao, Chuanbin; Dinarvand, Meshkat; Fatahi, Yousef; Atyabi, Fatemeh.

In: International Journal of Pharmaceutics, Vol. 524, No. 1-2, 30.05.2017, p. 312-329.

Research output: Contribution to journalReview article

Mottaghitalab, F, Rastegari, A, Farokhi, M, Dinarvand, R, Hosseinkhani, H, Ou, KL, Pack, DW, Mao, C, Dinarvand, M, Fatahi, Y & Atyabi, F 2017, 'Prospects of siRNA applications in regenerative medicine', International Journal of Pharmaceutics, vol. 524, no. 1-2, pp. 312-329. https://doi.org/10.1016/j.ijpharm.2017.03.092
Mottaghitalab F, Rastegari A, Farokhi M, Dinarvand R, Hosseinkhani H, Ou KL et al. Prospects of siRNA applications in regenerative medicine. International Journal of Pharmaceutics. 2017 May 30;524(1-2):312-329. https://doi.org/10.1016/j.ijpharm.2017.03.092
Mottaghitalab, Fatemeh ; Rastegari, Ali ; Farokhi, Mehdi ; Dinarvand, Rassoul ; Hosseinkhani, Hossein ; Ou, Keng Liang ; Pack, Daniel W. ; Mao, Chuanbin ; Dinarvand, Meshkat ; Fatahi, Yousef ; Atyabi, Fatemeh. / Prospects of siRNA applications in regenerative medicine. In: International Journal of Pharmaceutics. 2017 ; Vol. 524, No. 1-2. pp. 312-329.
@article{d8855624f77e494ca2b6eee350e703df,
title = "Prospects of siRNA applications in regenerative medicine",
abstract = "Small interfering RNA (siRNA) has established its reputation in the field of tissue engineering owing to its ability to silence the proteins that inhibit tissue regeneration. siRNA is capable of regulating cellular behavior during tissue regeneration processes. The concept of using siRNA technology in regenerative medicine derived from its ability to inhibit the expression of target genes involved in defective tissues and the possibility to induce the expression of tissue-inductive factors that improve the tissue regeneration process. To date, siRNA has been used as a suppressive biomolecule in different tissues, such as nervous tissue, bone, cartilage, heart, kidney, and liver. Moreover, various delivery systems have been applied in order to deliver siRNA to the target tissues. This review will provide an in-depth discussion on the development of siRNA and their delivery systems and mechanisms of action in different tissues.",
keywords = "Delivery systems, Gene expression, siRNA, Tissue engineering",
author = "Fatemeh Mottaghitalab and Ali Rastegari and Mehdi Farokhi and Rassoul Dinarvand and Hossein Hosseinkhani and Ou, {Keng Liang} and Pack, {Daniel W.} and Chuanbin Mao and Meshkat Dinarvand and Yousef Fatahi and Fatemeh Atyabi",
year = "2017",
month = "5",
day = "30",
doi = "10.1016/j.ijpharm.2017.03.092",
language = "English",
volume = "524",
pages = "312--329",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Prospects of siRNA applications in regenerative medicine

AU - Mottaghitalab, Fatemeh

AU - Rastegari, Ali

AU - Farokhi, Mehdi

AU - Dinarvand, Rassoul

AU - Hosseinkhani, Hossein

AU - Ou, Keng Liang

AU - Pack, Daniel W.

AU - Mao, Chuanbin

AU - Dinarvand, Meshkat

AU - Fatahi, Yousef

AU - Atyabi, Fatemeh

PY - 2017/5/30

Y1 - 2017/5/30

N2 - Small interfering RNA (siRNA) has established its reputation in the field of tissue engineering owing to its ability to silence the proteins that inhibit tissue regeneration. siRNA is capable of regulating cellular behavior during tissue regeneration processes. The concept of using siRNA technology in regenerative medicine derived from its ability to inhibit the expression of target genes involved in defective tissues and the possibility to induce the expression of tissue-inductive factors that improve the tissue regeneration process. To date, siRNA has been used as a suppressive biomolecule in different tissues, such as nervous tissue, bone, cartilage, heart, kidney, and liver. Moreover, various delivery systems have been applied in order to deliver siRNA to the target tissues. This review will provide an in-depth discussion on the development of siRNA and their delivery systems and mechanisms of action in different tissues.

AB - Small interfering RNA (siRNA) has established its reputation in the field of tissue engineering owing to its ability to silence the proteins that inhibit tissue regeneration. siRNA is capable of regulating cellular behavior during tissue regeneration processes. The concept of using siRNA technology in regenerative medicine derived from its ability to inhibit the expression of target genes involved in defective tissues and the possibility to induce the expression of tissue-inductive factors that improve the tissue regeneration process. To date, siRNA has been used as a suppressive biomolecule in different tissues, such as nervous tissue, bone, cartilage, heart, kidney, and liver. Moreover, various delivery systems have been applied in order to deliver siRNA to the target tissues. This review will provide an in-depth discussion on the development of siRNA and their delivery systems and mechanisms of action in different tissues.

KW - Delivery systems

KW - Gene expression

KW - siRNA

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=85017368427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017368427&partnerID=8YFLogxK

U2 - 10.1016/j.ijpharm.2017.03.092

DO - 10.1016/j.ijpharm.2017.03.092

M3 - Review article

C2 - 28385649

AN - SCOPUS:85017368427

VL - 524

SP - 312

EP - 329

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1-2

ER -